Status:
COMPLETED
Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis
Lead Sponsor:
Zagazig University
Conditions:
Postpartum Endometritis
Wound Infection
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The study aims to assess the beneficial value of vaginal preparation with chlorhexidine gluconate 0.05% before cesarean delivery of cases in labor in reduction of postoperative endometritis, fever and...
Detailed Description
Despite the demonstrated effectiveness of the vaginal cleansing in the previous study, yet this has not been adopted within obstetric practice internationally and does not feature within the NICE Intr...
Eligibility Criteria
Inclusion
- Gestational age ≥28 weeks.
- Cases had cesarean section after start of labor.
Exclusion
- Women with known allergy to chlorhexidine gluconate or any of its ingredients.
- Women with diagnosed group B streptococcus (GBS) colonization.
- Women with active infection during the procedure.
- Women did not receive the standard preoperative antibiotic prophylaxis.
- Women with diagnosis of chorioamnionitis.
- Prolonged rupture of membranes \>7 days
Key Trial Info
Start Date :
May 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
840 Patients enrolled
Trial Details
Trial ID
NCT04385680
Start Date
May 15 2020
End Date
August 30 2022
Last Update
September 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armed Forces Hospitals Southern Region
Khamis Mushait, Saudi Arabia, 62411